John Lepore leaves as GSK reshuffles R&D

Senior vice president and head of research at GSK (LSE: GSK), John Lepore, has left the UK pharma major.

His departure comes at a time when the London-based drugmaker is re-shuffling its R&D teams to create a distinct focus around each of its core therapy area.

Dr Lepore had been with GSK since 2006 and spent nearly six years in the head of research role, leading more than 1,000 researchers, scientists and physicians working to identify new drug targets, discover novel drug candidates, and demonstrate safety and proof of mechanism in clinical studies.